Skip to main content
Figure 1 | Malaria Journal

Figure 1

From: Identification of active Plasmodium falciparum calpain to establish screening system for Pf-calpain-based drug development

Figure 1

The enzymatically active form of Pf -calpain is identified. A) Schematic diagram of the full-length Pf-calpain and three recombinant Pf-calpain constructs. Cys 1035, His 1371, and Asn 1391 were indicated in catalytic subdomain IIa and IIb, respectively. The predicted histidine (His 1179) and asparagine (Asn 1195) residues were shown in red. These residues were further analysed. Black boxes indicate the recognition sites of anti-Pf calpain antibodies. Left, anti-Pf CapnA antibody; Right, anti-Pf CapnB antibody. B) Western blot of purified recombinant Pf-calpains using an anti-Pf-calpain antibodies. C) Calpain enzymatic activity measured by the fluorogenic substrate assay. D) Calpain enzymatic activity measured by gelatin zymography.

Back to article page